Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry.
Anna DryndaAgnieszka PadjasKrzysztof WójcikRadosław DziedzicGrzegorz BiedrońKatarzyna Wawrzycka-AdamczykAnna WłudarczykJoanna WilańskaJacek MusiałZbigniew ZdrojewskiZenobia CzuszyńskaAnna MasiakMaria MajdanRadosław JeleniewiczHanna Augustyniak-BartosikKatarzyna JakuszkoMagdalena KrajewskaAlicja Dębska-ŚlizieńHanna StoroniakBarbara Bułło-PionteckaWitold TłustochowiczJoanna Kur-ZalewskaMałgorzata WisłowskaPiotr GłuszkoMarta MadejEwa JassemIwona Damps-KonstańskaEugeniusz KucharzMarek BrzoskoMarcin MilchertAnna Hawrot-KaweckaJoanna Miłkowska-DymanowskaPaweł GórskiAnna Lewandowska-PolakJoanna MakowskaJoanna ZalewskaLech ZarębaStanisława Bazan-SochaPublished in: Journal of immunology research (2024)
Cardiovascular symptoms were more prevalent in the ANCA-negative subset than in the MPO-ANCA-positive one. Since EGPA and GPE HE share similarities in clinics, diagnostic misleading may result in an inappropriate therapeutic approach. Further studies are needed to optimize their differentiation and tailored therapy, including biologics.